Apollo Hospitals Enterprise has announced a Rs 6,000 crore investment over five years to add 3,500 beds in response to the rising instances of non-communicable diseases (NCDs) such as cancer, diabetes, and cardiovascular issues.
The expansion will roll out in two phases, targeting major urban centres with a strategic focus on specialties like oncology, cardiology, neurosciences, and gastroenterology.
In the first phase, Rs 2,880 crore will be used by FY26 to add 1,737 beds in Pune, Kolkata, Hyderabad, and Gurugram. The second phase will add 1,775 beds in Chennai, Varanasi, Mumbai, and Lucknow over three to four years with an investment of Rs 3,220 crore. While the focus remains on tier-I cities, Apollo also intends to expand into tier-II centres.
Joint Managing Ddirector of Apollo Hospitals, Sangita Reddy, stated, “Apollo is focused on strengthening its centres of excellence in cardiac sciences, oncology, neurosciences, orthopedics and gastro sciences.” She further added that the growth will be through “a combination of asset acquisitions, greenfield projects and brownfield developments.”
